Chargement en cours...
Interplay of Epidermal Growth Factor Receptor and Signal Transducer and Activator of Transcription 3 in Prostate Cancer: Beyond Androgen Receptor Transactivation
SIMPLE SUMMARY: Androgen receptor (AR) signaling mainly controls prostate cancer (PCa) growth. Hence, the conventional regimen for PCa includes androgen deprivation therapy (ADT) or antiandrogen in order to reduce PCa recurrence. However, castration-resistant prostate cancer (CRPC) is insensitive to...
Enregistré dans:
| Publié dans: | Cancers (Basel) |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8307975/ https://ncbi.nlm.nih.gov/pubmed/34298665 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13143452 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|